Insight into the relationship between forced vital capacity and transfer of the lungs for carbon monoxide in patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Soumagne, Thibaud
Quetantb, Sebastien [2 ]
Guillien, Alicia [3 ]
Falque, Loic [2 ]
Hess, David [4 ]
Aguilaniu, Bernard [4 ,5 ]
Degano, Bruno [1 ,6 ,7 ]
机构
[1] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Pneumol & Reanimat Resp, Clamart, France
[2] Ctr Hosp Univ Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, Pole Thorax & Vaisseaux, Grenoble, France
[3] Univ Grenoble Alpes, Inst Avancee Biosci IAB, Epidemiol Environm Appl Reprod & Sante Resp, INSERM,CNRS,U1209, Grenoble, France
[4] Assoc Complementar Connaissances & Prat Pneumol a, Programme Colibri, 19 Ave Marcelin Berthelot, F-38100 Grenoble, France
[5] Univ Grenoble Alpes, Grenoble, France
[6] Univ Grenoble Alpes, Lab HP2, INSERM U1300, Grenoble, France
[7] CHU Grenoble Alpes, Serv Hosp Univ Pneumol Physiol, F-38043 Grenoble, France
来源
关键词
Idiopathic pulmonary fibrosis; Pulmonary function tests; Forced vital capacity; Transfer of the lungs for carbon monoxide; Introduction; CLINICAL-PRACTICE; REFERENCE VALUES; DISEASE; PREDICTION; DIAGNOSIS; SURVIVAL; DLCO; KCO; FVC;
D O I
10.1016/j.resmer.2023.101042
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Forced vital capacity (FVC) is routinely used to quantify the severity and identify the progression of idiopathic pulmonary fibrosis (IPF). Although less commonly used, lung transfer of carbon monoxide (TLCO) correlates better with the severity of IPF than does FVC.Methods: Aiming at studying how FVC behaves in relation to TLCO, we analysed cross-sectional data from 430 IPF patients, of which 221 had at least 2 assessments (performed 2.4 +/- 1.9 years apart) available for longitudinal analyses. Thresholds for identifying "abnormal" FVC and TLCO values were the statistically-defined lower limits of normal (LLN). For patients with longitudinal data, mean annual absolute declines of FVC and TLCO were calculated. Results: The correlation between FVC and TLCO (%predicted) was weak (R2=0.21). FVC was "abnormal" (i.e., 38% of patients while 84% of patients had an "abnormal" TLCO. A large majority of the 268 patients with a "normal" FVC had nevertheless an "abnormal" TLCO (n = 209; 78%). On longitudinal analysis, 67/221 patients had an annual absolute decline in FVC >= 5%, 34/221 had an annual absolute decline in TLCO >= 10%, and 22 had both.Conclusion: In IPF, a "normal" FVC should be viewed with caution as it is most often associated with an "abnormal" TLCO, a parameter that is strongly correlated with the morphological extent of the disease. Only 1/3 of the patients with a FVC-based progression criterion also had a TLCO progression criterion. In contrast, 2/3 of patients with a TLCO progression criterion also had a FVC progression criterion.(c) 2023 Published by Elsevier Masson SAS.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis Test Properties and Minimal Clinically Important Difference
    du Bois, Roland M.
    Weycker, Derek
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    Kartashov, Alex
    King, Talmadge E., Jr.
    Lancaster, Lisa
    Noble, Paul W.
    Sahn, Steven A.
    Thomeer, Michiel
    Valeyre, Dominique
    Wells, Athol U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) : 1382 - 1389
  • [22] Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
    Reichmann, William M.
    Yu, Yanni F.
    Macaulay, Dendy
    Wu, Eric Q.
    Nathan, Steven D.
    BMC PULMONARY MEDICINE, 2015, 15
  • [23] Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis
    William M. Reichmann
    Yanni F. Yu
    Dendy Macaulay
    Eric Q. Wu
    Steven D. Nathan
    BMC Pulmonary Medicine, 15
  • [24] Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) - modelling the myth
    Wijsenbeek, Marlies
    Santermans, Eva
    Ford, Paul
    Kreuter, Michael
    Verbruggen, Nadia
    Meyvisch, Paul
    Wuyts, Wim
    Brown, Kevin
    Lederer, David
    Maher, Toby
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis
    Nishiyama, Osamu
    Yamazaki, Ryo
    Sano, Akiko
    Yamagata, Toshiyuki
    Sano, Hiroyuki
    Iwanaga, Takashi
    Higashimoto, Yuji
    Kume, Hiroaki
    Tohda, Yuji
    CHRONIC RESPIRATORY DISEASE, 2016, 13 (01) : 40 - 47
  • [26] Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
    Zappala, C. J.
    Latsi, P. I.
    Nicholson, A. G.
    Colby, T. V.
    Cramer, D.
    Renzoni, E. A.
    Hansell, D. M.
    du Bois, R. M.
    Wells, A. U.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 830 - 835
  • [27] Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis
    Maher, Toby M.
    Stowasser, Susanne
    Voss, Florian
    Bendstrup, Elisabeth
    Kreuter, Michael
    Martinez, Fernando J.
    Sime, Patricia J.
    Stock, Christian
    RESPIROLOGY, 2023, 28 (12) : 1147 - 1153
  • [28] Relationship Between GAP Index or Stage, Quantitative Lung Fibrosis Scores and Disease Progression as Measured by Percent Predicted Forced Vital Capacity in Idiopathic Pulmonary Fibrosis
    Belloni, P.
    Cheung, D. S.
    Burgess, T.
    Odueyungbo, A.
    Stauffer, J. L.
    Kim, G.
    Brown, M.
    Goldin, J.
    Coimbra, A. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] ASSOCIATION OF CHANGE IN FORCED VITAL CAPACITY WITH HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH NEWLY DIAGNOSED IDIOPATHIC PULMONARY FIBROSIS
    Reichmann, W. M.
    Yu, Y.
    Macaulay, D.
    Nathan, S. D.
    VALUE IN HEALTH, 2015, 18 (03) : A259 - A259
  • [30] Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort
    Fainberg, Hernan P.
    Oldham, Justin M.
    Molyneaux, Philip L.
    Allen, Richard J.
    Kraven, Luke M.
    Fahy, William A.
    Porte, Joanne
    Braybrooke, Rebecca
    Saini, Gauri
    Karsdal, Morten A.
    Leeming, Diane J.
    Sand, Jannie M. B.
    Triguero, Isaac
    Oballa, Eunice
    Wells, Athol U.
    Renzoni, Elisabetta
    Wain, Louise, V
    Noth, Imre
    Maher, Toby M.
    Stewart, Iain D.
    Jenkins, R. Gisli
    LANCET DIGITAL HEALTH, 2022, 4 (12): : E862 - E872